Ellen Solomon

Q: What Schools Are Affiliated With Ellen Solomon

Ellen Solomon is affiliated with the following schools: University of Oxford, King's College London

Ellen Solomon's AcademicInfluence.com Rankings

Ellen Solomon

Biology

#12508

World Rank

#15987

Historical Rank

Genetics

#1377

World Rank

#1479

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Ellen Solomon Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Ellen Solomon's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Localization of the gene for familial adenomatous polyposis on chromosome 5 (1987) (1379)
Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. (1990) (626)
Chromosome aberrations and cancer. (1991) (582)
Assessment of Minimal Residual Disease in Standard-Risk AML. (2016) (543)
Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. (1991) (478)
The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress (2009) (452)
Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: result of the Randomized MRC Trial. (1999) (424)
PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia. (1996) (365)
Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics (1999) (357)
The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto‐oncoprotein PML. (1995) (345)
Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Groupe Français de Cytogénétique Hématologique, Groupe de Français d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED 1 European Community-Concerted Action "Mole (2000) (333)
Prospective minimal residual disease monitoring to predict relapse of acute promyelocytic leukemia and to direct pre-emptive arsenic trioxide therapy. (2009) (325)
SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation. (1999) (315)
BRCA1 : BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair. (2004) (288)
Chromosomal localization of human cellular homologues of two viral oncogenes (1982) (286)
DNA topoisomerase II in therapy-related acute promyelocytic leukemia. (2005) (261)
BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistance. (2011) (237)
The β2-microglobulin gene is on chromosome 15 and not in the HL-A region (1975) (231)
Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia. (2007) (199)
Assignment of the structural gene for the third component of human complement to chromosome 19. (1982) (198)
The genetic control of HLA-A and B antigens in somatic cell hybrids: requirement for beta2 microglobulin. (1978) (192)
Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia. (2005) (189)
Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. (1996) (177)
The molecular pathogenesis of acute promyelocytic leukaemia: implications for the clinical management of the disease. (2003) (170)
Diagnosis of acute promyelocytic leukaemia by RT‐PCR: detection of PML‐RARA and RARA‐PML fusion transcripts (1992) (165)
Human T cell leukemia viruses use a receptor determined by human chromosome 17. (1988) (156)
Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia. (1997) (149)
Chromosomal localisation of the human homologues to the oncogenes erbA and B. (1984) (146)
Complex Regulation of the BRCA1 Gene* (1997) (145)
The gene, MIC4, which controls expression of the antigen defined by monoclonal antibody F10.44.2, is on human chromosome 11 (1982) (144)
Clinical and molecular features of the hereditary mixed polyposis syndrome. (1997) (141)
Establishing the presence of the t( 15; 17) in suspected acute promyelocytic leukaemia: cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the M.R.C. ATRA trial (1996) (133)
Human gene mapping using an X/autosome translocation (1976) (116)
In vivo and in vitro characterization of the B1 and B2 zinc-binding domains from the acute promyelocytic leukemia protooncoprotein PML. (1996) (114)
Distinct transcription start sites generate two forms of BRCA1 mRNA. (1995) (109)
Genetic analysis of BRCA1 ubiquitin ligase activity and its relationship to breast cancer susceptibility. (2006) (108)
Molecular cloning of alpha 5(IV) collagen and assignment of the gene to the region of the X chromosome containing the Alport syndrome locus. (1990) (108)
A novel gene encoding a B-box protein within the BRCA1 region at 17q21.1. (1994) (106)
Identification and characterization of the human type II collagen gene (COL2A1). (1985) (100)
Interactions with LC3 and polyubiquitin chains link nbr1 to autophagic protein turnover (2009) (100)
Human myosin heavy chain genes assigned to chromosome 17 using a human cDNA clone as probe (1985) (100)
Tumor Suppressor p53 Is Required To Modulate BRCA1 Expression (2000) (97)
The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations. The BRCA1 Exon 13 Duplication Screening Group. (2000) (96)
Assignment of the human acid α‐glucosidase gene (αGLU) to chromosome 17 using somatic cell hybrids (1979) (96)
Human elastin gene: new evidence for localization to the long arm of chromosome 7. (1991) (94)
EVOLUTION OF SICKLE VARIANT GENE (1979) (93)
The chromosomal location of T‐cell receptor genes and a T cell rearranging gene: possible correlation with specific translocations in human T cell leukaemia. (1985) (93)
Nucleotide sequence of cDNA encoding human alpha 2-macroglobulin and assignment of the chromosomal locus. (1985) (92)
The human alpha 2(XI) collagen (COL11A2) chain. Molecular cloning of cDNA and genomic DNA reveals characteristics of a fibrillar collagen with differences in genomic organization. (1989) (86)
A highly polymorphic region 3' to the human type II collagen gene (1985) (84)
THRA1 and D17S183 flank an interval of < 4 cM for the breast-ovarian cancer gene (BRCA1) on chromosome 17q21. (1993) (84)
Current status of the molecular characterization of the ovarian cancer antigen CA125 and implications for its use in clinical screening. (2003) (82)
Genetic mapping of hereditary mixed polyposis syndrome to chromosome 6q. (1996) (81)
Isolation and characterisation of the NBR2 gene which lies head to head with the human BRCA1 gene. (1997) (81)
Neighbor of Brca1 gene (Nbr1) functions as a negative regulator of postnatal osteoblastic bone formation and p38 MAPK activity (2010) (80)
The human collagen X gene. Complete primary translated sequence and chromosomal localization. (1991) (79)
Minimal residual disease detection in acute promyelocytic leukemia by reverse-transcriptase PCR: evaluation of PML-RAR alpha and RAR alpha-PML assessment in patients who ultimately relapse. (1996) (75)
Evidence for direct involvement of epirubicin in the formation of chromosomal translocations in t(15;17) therapy-related acute promyelocytic leukemia. (2010) (71)
The 5' end of the BRCA1 gene lies within a duplicated region of human chromosome 17q21. (1996) (70)
Chromosomal assignments of the genes coding for human types II, III, and IV collagen: a dispersed gene family. (1985) (67)
Acute promyelocytic leukemia: a paradigm for differentiation therapy. (2010) (64)
Expression of human transferrin receptor is controlled by a gene on chromosome 3: Assignment using species specificity of a monoclonal antibody (1982) (63)
Biosynthesis of the first component of complement by human fibroblasts. (1977) (63)
Report of the committee on the genetic constitution of chromosome 17. (1989) (63)
Introduction of a human X-6 translocation chromosome into a mouse teratocarcinoma: investigation of control of HLA-A, B, C expression. (1982) (59)
Immunochemical analysis of the N-acetyl hexosaminidases in human-mouse hybrids made using a double selective system. (1977) (57)
Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia. (1997) (56)
Mutations of the BRCA1 gene in human cancer. (1996) (55)
RARα-PLZF overcomes PLZF-mediated repression of CRABPI, contributing to retinoid resistance in t(11;17) acute promyelocytic leukemia (2007) (54)
THE FREQUENCY AND MECHANISM OF LOSS OF HETEROZYGOSITY ON CHROMOSOME 11q IN BREAST CANCER (1996) (54)
The nm23 gene maps to human chromosome band 17q22 and shows a restriction fragment length polymorphism with bg/II (1992) (51)
Assignment of the human locus determining phosphoglycolate phosphatase (PGP) to chromosome 16 (1980) (51)
Downregulation of the Wnt inhibitor CXXC5 predicts a better prognosis in acute myeloid leukemia. (2015) (51)
Mapping of the gene coding for the human GM2 activator protein to chromosome 5 (1985) (51)
Genetic analysis of BRCA 1 ubiquitin ligase activity and its relationship to breast cancer susceptibility (2006) (50)
Chromosome assignment of monoclonal antibody‐defined determinants on human leukemic cells (1983) (49)
Genetic analysis of the 15;17 chromosome translocation associated with acute promyelocytic leukemia. (1983) (49)
Identification of Residues Required for the Interaction of BARD1 with BRCA1* (2002) (49)
Assignment of the DIA1 locus to chromosome 22 (1977) (48)
Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants (2005) (47)
The human T-cell receptor α-chain gene maps to chromosome 14 (1985) (47)
NBR1 interacts with fasciculation and elongation protein zeta-1 (FEZ1) and calcium and integrin binding protein (CIB) and shows developmentally restricted expression in the neural tube. (2002) (47)
Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARalpha rearrangement in newly diagnosed AML. The Medical Research Council (MRC) Adult Leukaemia Working Party. (1999) (46)
An increased frequency of the 5A allele in the promoter region of the MMP3 gene is associated with abdominal aortic aneurysms. (2007) (45)
Long‐ and short‐term outcomes in renal allografts with deceased donors: A large recipient and donor genome‐wide association study (2018) (44)
Localization of a human heat-shock HSP 70 gene sequence to chromosome 6 and detection of two other loci by somatic-cell hybrid and restriction fragment length polymorphism analysis (1987) (41)
Germline BRCA1 promoter deletions in UK and Australian familial breast cancer patients: Identification of a novel deletion consistent with BRCA1:ψBRCA1 recombination (2002) (41)
Regional localization of the human alpha 2(I) collagen gene on chromosome 7 by molecular hybridization. (1983) (41)
A somatic cell hybrid map of the long arm of human chromosome 17, containing the familial breast cancer locus (BRCA1). (1993) (37)
The epigenetic regulator PLZF represses L1 retrotransposition in germ and progenitor cells (2013) (37)
Construction of a genetic map of human chromosome 17 by use of chromosome-mediated gene transfer. (1988) (37)
Lymphocyte radiosensitivity in BRCA1 and BRCA2 mutation carriers and implications for breast cancer susceptibility (2007) (37)
The search for the familial breast/ovarian cancer gene. (1993) (36)
Isolation and characterization of a human collagen α 1(I)-like gene from a cosmid library (1982) (35)
Confirmation and further regional assignment of aminoacylase 1 (ACY‐1) on human chromosome 3 using a simplified detection method (1980) (35)
Integration of Ecogpt and SV40 early region sequences into human chromosome 17: a dominant selection system in whole cell and microcell human‐mouse hybrids. (1983) (34)
Relationship between FLT 3 mutation status , biologic characteristics , and response to targeted therapy in acute promyelocytic leukemia (2005) (33)
Chromosomal localization of zinc finger protein genes in man and mouse. (1989) (33)
Identification of MIC5, a human X-linked gene controlling expression of a cell surface antigen: definition by a monoclonal antibody raised against a human X mouse somatic cell hybrid. (1982) (33)
A human T‐cell antigen receptor beta chain gene maps to chromosome 7. (1984) (33)
HLS5, a Novel RBCC (Ring Finger, B Box, Coiled-coil) Family Member Isolated from a Hemopoietic Lineage Switch, Is a Candidate Tumor Suppressor* (2004) (33)
Molecular Pathogenesis of Secondary Acute Promyelocytic Leukemia (2011) (33)
Assignment of apolipoprotein H (APOH: beta-2-glycoprotein I) to human chromosome 17q23----qter; determination of the major expression site. (1992) (32)
PML nuclear bodies in the pathogenesis of acute promyelocytic leukemia: active players or innocent bystanders? (2009) (32)
The human alpha 2(XI) collagen gene (COL11A2) maps to the centromeric border of the major histocompatibility complex on chromosome 6. (1989) (31)
Localization of the oncogene c‐erbA1 immediately proximal to the acute promyelocytic leukaemia breakpoint on chromosome 17 (1985) (31)
Molecular analysis of simple variant translocations in acute promyelocytic leukemia (1994) (30)
Expression of a Truncated Brca1 Protein Delays Lactational Mammary Development in Transgenic Mice (2004) (30)
Pml nuclear body disruption cooperates in APL pathogenesis and impairs DNA damage repair pathways in mice. (2018) (28)
The human type II collagen gene (COL2A1) assigned to 12q14.3 (1986) (28)
Regional localization of CD18, the β‐subunit of the cell surface adhesion molecule LFA‐1, on human chromosome 21 by in situ hybridization (1988) (28)
Molecular cloning and chromosomal localization to 17q21 of the human WNT3 gene. (1993) (27)
Physical mapping, cloning, and identification of genes within a 500-kb region containing BRCA1. (1995) (27)
Assignment of tissue-type plasminogen activator to chromosome 8 in man and identification of a common restriction length polymorphism within the gene. (1984) (27)
Gene replacement with the human BRCA1 locus: tissue specific expression and rescue of embryonic lethality in mice (2000) (27)
The T-lineage-affiliated CD2 gene lies within an open chromatin environment in acute promyelocytic leukemia cells. (2002) (26)
Second international workshop on human chromosome 17. (1991) (25)
Molecular genetics of sporadic and familial breast cancer. (1995) (24)
The assignment of the genes coding for human complement components C6 and C7 to chromosome 5 (1990) (24)
Structural evolution of the BRCA1 genomic region in primates. (2004) (24)
Genetic aspects of cancer. (1993) (23)
Isolation of the murine Nbr1 gene adjacent to the murine Brca1 gene. (1996) (23)
Assignment of the gene coding for both the beta-subunit of prolyl 4-hydroxylase and the enzyme disulfide isomerase to human chromosome region 17p11----qter. (1988) (23)
The cryptic IRF2BP2-RARA fusion transforms hematopoietic stem/progenitor cells and induces retinoid-sensitive acute promyelocytic leukemia (2017) (23)
The ubiquitin-homology gene PIC1: characterization of mouse (Pic1) and human (UBL1) genes and pseudogenes. (1998) (23)
Genetic and physical map of the von Recklinghausen neurofibromatosis (NF1) region on chromosome 17. (1990) (23)
MAP1B Interaction with the FW Domain of the Autophagic Receptor Nbr1 Facilitates Its Association to the Microtubule Network (2012) (22)
A previously uncharacterized gene, PML, is fused to the retinoic acid receptor alpha gene in acute promyelocytic leukaemia. (1992) (21)
Characterization and mapping of microdissected genomic clones from the adenomatous polyposis coli (APC) region. (1991) (21)
Confirmation that the Type I collagen gene on chromosome 17 is COL1A1 (α1(I)), using a human genomic probe (1984) (21)
Assignment of the human acid alpha-glucosidase gene (alphaGLU) to chromosome 17 using somatic cell hybrids. (1979) (20)
Mapping of the gene TCF2 coding for the transcription factor LFB3 to human chromosome 17 by polymerase chain reaction. (1990) (19)
The human ICAM2 gene maps to 17q23-25. (1991) (19)
Molecular analysis of the t(15;17) translocation in acute promyelocytic leukaemia. (1992) (19)
Regional assignment of the human gene coding for a multifunctional polypeptide (P4HB) acting as the beta-subunit of prolyl 4-hydroxylase and the enzyme protein disulfide isomerase to 17q25. (1991) (19)
Exclusion of the alpha 1(II) cartilage collagen gene as the mutant locus in type IA osteogenesis imperfecta. (1985) (19)
Progress towards construction of a total restriction fragment map of a human chromosome. (1987) (19)
Autophagic receptors Nbr1 and p62 coregulate skeletal remodelling (2010) (18)
Genetic analysis of colorectal cancer. (1989) (18)
Studies on inherited cancers: outcomes and challenges of 25 years. (1997) (18)
Assignment of the gene coding for the alpha-subunit of prolyl 4-hydroxylase to human chromosome region 10q21.3-23.1. (1989) (18)
Brca1 expression is regulated by a bidirectional promoter that is shared by the Nbr1 gene in mouse. (2004) (17)
Genetics and cancer : a second look (1995) (16)
Biallelic mutation of MSH2 in primary human cells is associated with sensitivity to irradiation and altered RAD51 foci kinetics (2007) (16)
Confirmation of the assignment of human biliverdin reductase to chromosome 7 (1984) (16)
Localization of the oncogene c‐erbA2 to human chromosome 3 (1987) (16)
A case of acute monocytic leukemia with t(11;17) involving a rearrangement of MLL-1 and a region proximal to the RARA gene. (1994) (15)
The human T-cell receptor alpha-chain gene maps to chromosome 14. (1985) (15)
Cloning of the murine homolog of the leukemia-associated PML gene (1995) (15)
Linkage analysis of early-onset breast and ovarian cancer families, with markers on the long arm of chromosome 17. (1993) (15)
Rapid and efficient ATM mutation detection by fluorescent chemical cleavage of mismatch: identification of four novel mutations (1999) (14)
Identification of a C/G polymorphism in the promoter region of the BRCA1 gene and its use as a marker for rapid detection of promoter deletions (1999) (14)
Fine Mapping of Probes in the Adenomatous Polyposis Coli Region of Chromosome 5 by In Situ Hybridization (1991) (13)
Assignment of the locus ACONM to chromosome 22. (1978) (13)
Proceedings of the Second International Workshop on Human Chromosome 17 Mapping 1991 (1991) (13)
Assignment of complement components C4 binding protein (C4BP) and factor H (FH) to human chromosome 1q, using cDNA probes (1988) (13)
Chromosomal assignment of seven human genomic DNA sequences associated with restriction fragment length polymorphisms (1986) (13)
The human myoglobin gene: a third dispersed globin locus in the human genome. (1984) (12)
Evolution of sickle variant gene. 1979. (1992) (12)
Incidence of the 15q+;17q- chromosome translocation in acute promyelocytic leukaemia (APL). (1985) (12)
Localization of a second NM23 gene, NME2, to chromosome 17q21-q22. (1993) (12)
9 – Genetics of Colorectal Cancer (1991) (12)
Construction and regional localization of clones from a NotI linking library from human chromosome 17q. (1991) (11)
Assignment of the gene for the thrid component of human complement (C3) to chromosome 19 using human mouse somatic cell hybrids (1982) (11)
Detection of minimal residual disease (MRD) in APL by "real-time" RT-PCR: Analysis of cases entered into the UK MRC ATRA trial. (1999) (10)
Ordering of 66 STSs along the entire short arm of human chromosome 17 and chromosome assignment of a transcribed sequence (FMR1L2) homologous to FMR1. (1996) (10)
Report of the committee on the genetic constitution of chromosome 17. (1990) (9)
Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARα rearrangement in newly diagnosed AML (1999) (9)
Assignment of the gene coding for the alpha 1 chain of collagen type XIII (COL13A1) to human chromosome region 10q11----qter. (1989) (9)
A short region of the promoter of the breast cancer associated PLU-1 gene can regulate transcription in vitro and in vivo. (2004) (9)
15/17 chromosome translocation in acute promyelocytic leukemia. (1982) (8)
Confirmation of the assignment of the locus determining ADA to chromosome 20 in man: data on possible synteny of ADA and ITP in human-Chinese hamster somatic cell hybrids. (1976) (8)
Human chromosome 11 carries at least four genes controlling expression of cell-surface antigens (1983) (8)
Localization of the retinoid X receptor alpha gene (RXRA) to chromosome 9q34 (1993) (8)
Molecular Detection of Minimal Residual Disease Provides the Most Powerful Independent Prognostic Factor Irrespective of Clonal Architecture in Nucleophosmin (NPM1) Mutant Acute Myeloid Leukemia (2014) (8)
Yeast artificial chromosomes for the molecular analysis of the familial polyposis APC gene region. (1992) (7)
Towards cloning the familial breast-ovarian cancer gene on chromosome 17. (1994) (7)
RFLP for the human erb-A1 gene. (1986) (7)
A long-range restriction map of human chromosome 5q21-q23. (1993) (7)
The gene for the α2 chain of the human fibrillar collagen type XI (COL11A2) assigned to the short arm of chromosome 6 (1990) (7)
Regional mapping of chromosome 15. (1978) (7)
Abstracts of workshop presentations pp. 1040-1056 (1989) (6)
Gene mapping data – recommendations for more efficient dissemination (1983) (6)
Human gene mapping 11. London Conference (1991). Eleventh International Workshop on Human Gene Mapping. London, UK, August 18-22, 1991. (1991) (6)
PHYSICAL MAPPING OF THE APC REGION (1991) (6)
Multiple tandem 18-kb sequences clustered in the region of the acute promyelocytic leukemia breakpoint on chromosome 17. (1989) (6)
Human gene mapping 11. London Conference (1991). Eleventh International Workshop on Human Gene Mapping. London, UK, August 18-22, 1991. (1991) (6)
The relationship between FLT3 mutation status: biological characteristics and outcome in patients with acute promyelocytic leukaemia. (2003) (6)
Assignment of a structural gene for type I collagen to chromosome 7. (1978) (5)
Localization of MIC5 to the region between HPRT and G6PD on the human X chromosome (1987) (5)
Abstracts of workshop presentations pp. 948-967 (1989) (5)
Abstracts of workshop presentations pp. 1023-1039 (1989) (5)
Monoclonal Antibodies as Tools for Human Genetic Analysis (1980) (5)
Truncated TSG101 transcripts are present in peripheral blood from both familial breast cancer patients and controls. (1998) (5)
Localization of the human RNA polymerase I transcription factor gene (UBTF) to the D17S183 locus on chromosome 17q21 and construction of a long-range restriction map of the region. (1995) (5)
Immunoglobulin heavy chain genes in humans are located on chromosome. (1981) (5)
Calendar of Events: 1991 — 1992 (1991) (4)
Abstracts of workshop presentations pp. 1057-1074 (1989) (4)
Summary of Human Gene Map, New Haven, HGM – 1, 1973, ‘Data 1' (1989) (4)
GENETICS OF THE T-CELL RECEPTOR (1985) (4)
Evaluation of Prospective Detection of PML-RARA and RARA-PML Fusion Transcripts by Real-Time Quantitative PCR (RQ-PCR) To Direct Pre-Emptive Therapy with Arsenic Trioxide (ATO) in Acute Promyelocytic Leukemia (APL) Patients Treated in the UK MRC AML15 Trial. (2007) (4)
Use of a BRCA1 peptide validates MS110 as a BRCA1‐specific antibody in immunohistochemistry (2008) (3)
Genetic heterogeneity of early-onset familial breast cancer (1992) (3)
RT-PCR in diagnosis and disease monitoring of acute promyelocytic leukemia (APL). (1998) (3)
Therapy-related leukaemias with balanced translocations can arise from pre-existing clonal haematopoiesis (2021) (3)
Rexinoid therapy bypasses the differentiation block associated with acute promyelocytic leukemia harboring the PLZF/RAR alpha rearrangement. (2001) (3)
The role of molecular diagnosis & residual disease monitoring in APL: Results of the MRC ATRA trial (1998) (3)
A highly polymorphic locus on chromosome 11 which has homology to a collagen triple-helix coding sequence. (1989) (3)
BETA-2-MICROGLOBULIN GENE IS ON CHROMOSOME-15 AND NOT IN HL-A REGION (1975) (3)
Abstracts of workshop presentations pp. 1075-1091 (1989) (3)
Pml Nuclear Body Disruption Cooperates in APL Pathogenesis, Impacting DNA Damage Repair Pathways (2016) (3)
Abstracts of workshop presentations pp. 1106-1116 (1989) (2)
Evaluation of the use of S1 nuclease to detect small length variations in genomic DNA. (1989) (2)
Molecular characterisation of patients with APL entered into the UK MRC ATRA trial: Relationship of PML breakpoint with additional cytogenetic abnormalities and outcome [Abstract] (1997) (2)
Real-Time Detection of PML-RARA and RARA-PML Fusion Transcripts in High Risk Acute Promyelocytic Leukemia (APL) Treated with Arsenic Trioxide (ATO): Implications for Realization of Pre-Emptive Therapy for Molecular Relapse. (2006) (2)
Confirmation of the assignment of the locus determining ADA to chromosome 20 in man: data on possible synteny of ADA and ITP in human-Chinese hamster somatic cell hybrids. (1976) (2)
Linkage relationships of the HL-A system and beta 2 microglobulin. (1975) (2)
New regulators of the BRCA1 response to genotoxic stress (2010) (2)
Regional mapping of 22 microclones around the adenomatous polyposis coli (APC) locus on chromosome 5q (1991) (2)
Contents Vol. 55, 1990 (1990) (1)
Single base pair alterations as the predominant category of mutation in type I osteogenesis imperfecta. (1989) (1)
Disruption Of PML Nuclear Bodies Cooperates In The Pathogenesis Of Acute Promyelocytic Leukemia (2013) (1)
The RET E616Q Variant is a Gain of Function Mutation Present in a Family with Features of Multiple Endocrine Neoplasia 2A (2017) (1)
The IRF2BP2-RARα Fusion Generated By a Cryptic Rearrangement Transforms Hematopoietic Stem/Progenitor Cells and Induces Retinoid Sensitive Acute Promyelocytic Leukemia (APL) (2014) (1)
Sensitive Detection of FIP1L1-PDGFRA Fusion Transcripts by Real-Time Quantitative RT-PCR (RQ-PCR) Reveals Achievement of Molecular Remission in Chronic Eosinophilic Leukemia Treated with Low-Dose Imatinib Therapy. (2005) (1)
Workshop on mapping by somatic cell hybridization. (1982) (1)
Report of the committee on the genetic constitution of chromosome 17. (1988) (1)
The human alpha 2(IV) collagen gene, COL4A2, is syntenic with the alpha 1(IV) gene, COL4A1, on chromosome 13. (1987) (1)
Identification of PLZF-Dmrs in Hematopoiesis Highlight a Novel Role of PLZF As a Guardian of Hematopoietic Genome Integrity (2014) (1)
Isolation and characterization of a human collagen alpha 1(I)-like gene from a cosmid library. (1982) (1)
Recent Advances in Understanding the Cellular Functions of BRCA1 (2009) (1)
Genetic mechanisms in carcinogenesis. (1983) (1)
Subject Index Vol. 52, 1989 (1989) (1)
HumanElastin Gene:New Evidence forLocalization totheLong Arm ofChromosome7 (1991) (0)
Subject Index Vol. 22, 1978 (1978) (0)
Index by Abstract Number (1989) (0)
The BRCA1 gene in sporadic breast and ovarian cancer (1995) (0)
Evaluation of prospective real-time quantitative PCR monitoring for minimal residual disease to predict relapse and direct molecularly targeted therapy with arsenic trioxide in acute promyelocytic leukaemia: analysis of 407 patients, including results of the MRC AML15 trial [Abstract] (2008) (0)
Use of quantitative PCR approaches to predict relapse and direct molecularly targeted therapy with arsenic trioxide (ATO) in acute promyelocytic leukaemia (APL)[Abstract] (2007) (0)
How Should We Prevent Hematologic Relapse of Acute Promyelocytic Leukemia? Reply (2010) (0)
Chromosome 5 Deletions as a Means of Defining the APC Region (1990) (0)
Assignment of the Gene Determining Human Acid α-Glucosidase (α-GLU) Using Somatic Cell Hybrids (2008) (0)
Nbr1 mutant mice exhibit age dependent increases in bone volume and mass (2004) (0)
SHORT REPORT Lymphocyte radiosensitivity in BRCA1 and BRCA2 mutation carriers and implications for breast cancer susceptibility (2007) (0)
Isolation of Coding Sequence from Cosmids and YACs by Exon Amplification (1994) (0)
positive chronic eosinophilic leukemia - FIP1L1-PDGFRA responses and achievement of complete molecular remission in Low-dose imatinib mesylate leads to rapid induction of major molecular (2013) (0)
Subject Index Vol. 16, 1976 (1976) (0)
References to the committee reports (1975) (0)
Molecular Pathogenesis of Secondary Acute (2011) (0)
Index by Keyword (1989) (0)
Analysis of mouse models with loss or mutations in Nbr1 demonstrate an age-dependent high bone mass due to altered osteoblast activity (2010) (0)
Strategies for Cloning the Gene for Adenomatous Polyposis Coli (1990) (0)
Defining The Translocation Mechanism In Therapy-Related Acute Promyelocytic Leukaemia (2009) (0)
Defining the landscape of resistance mutations in the context of modern treatment protocols for acute promyelocytic leukaemia (2009) (0)
Assessing BRCA1 activity in DNA damage repair using human induced pluripotent stem cells as an approach to assist classification of BRCA1 variants of uncertain significance (2021) (0)
Cells Chromatin Environment in Acute Promyelocytic Leukemia Gene Lies within an Open CD 2 The T-Lineage-affiliated Updated (2002) (0)
Title Page / Table of Contents / Abstracts (1991) (0)
BRCA1 and BRCA2: breaking the cycle and repairing the damage (2004) (0)
BRCA1 co localises with members of the ubiquitin cascade and can regulate conjunction of ubiquitin in cells (2003) (0)
The Genetical Society of Great Britain Abstracts of Papers presented at the hundred and seventy-seventh meeting of the Society held on 25th and 26th March 1975 in the University of Keele. (1975) (0)
Role of Nbr1 in bone remodeling (2009) (0)
Erratum: Neighbor of Brca1 gene (Nbr1) functions as a negative regulator of postnatal osteoblastic bone formation and p38 MAPK activity (Proceedings of the National Academy of Sciences of the United States of America (2010) 107 (12913-12918) DOI: 10.1073/pnas.0913058107) (2013) (0)
Long-and short-term outcomes in renal allografts with deceased donors : A (2018) (0)
Diagnosis and outcome prediction for childhood acute leukaemia by gene expression profiling (2004) (0)
Retinoic Acid: Result of the Randomized MRC Trial All-Trans Predict Prognosis in Acute Promyelocytic Leukemia Treated With Presenting White Blood Cell Count and Kinetics of Molecular Remission (2013) (0)
ASSIGNMENT OF GENE DETERMINING HUMAN ACID ALPHA-GLUCOSIDASE (ALPHA-GLU) USING SOMATIC-CELL HYBRIDS (1978) (0)
Thesolution structure oftheRINGfinger domain fromtheacutepromyelocytic leukaemia proto-oncoprotein PML (1995) (0)
Guidelines for interpreting abbreviations and specialized phrases in committee text and tables (1989) (0)
Defining the Landscape of Resistance Mutations in the Context of Modern Treatment Protocols for Acute Promyelocytic Leukemia (APL). (2008) (0)
IMMUNOCHEMICAL ANALYSIS OF HUMAN N-ACETYL HEXOSAMINIDASES IN HUMAN-MOUSE SOMATIC-CELL HYBRIDS (1977) (0)
Subject Index Vol. 56, 1991 (1991) (0)
Exclusion oftheul(II) cartilage collagen geneasthe mutantlocus intypeIAosteogenesis imperfecta (1985) (0)
A note on the use of HGML LIT literature file numbers (1989) (0)
Regulation of CD2 expression in acute promyelocytic leukemia (APL). (1999) (0)
Linkage relationships of the HL-A system and beta2 microglobulin. (1975) (0)
Molecular mechanisms underlying formation of balanced chromosomal rearrangements in therapy-related acute myeloid leukaemia (2009) (0)
Mitoxantrone induces DNA topoisomerase II cleavage at translocation breakpoint hotspot in PML gene in acute promyelocytic leukemia (2003) (0)
Therapy-Related Myeloid Neoplasms with Balanced Chromosome Rearrangements Frequently Arise from Pre-Existing Clonal Haematopoiesis (2018) (0)
Assignment oftheGeneCodingforthea-Subunit ofProlyl 4-Hydroxylase toHumanChromosomeRegion10q21.3-23.1 (1989) (0)
Reply to S. Nagai et al (2010) (0)
f Secondary Acute Promyelocytic Leukemia (2011) (0)
Molecular Characterization of the t(15;17)(q22;21) in Epirubicin-Related Acute Promyelocytic Leukaemia (2008) (0)
Contents, Vol. 52, 1989 (1989) (0)
Progress towards construction ofatotal restriction fragnent mapofahumanchromosome (1987) (0)
Abstracts of workshop presentations pp. 1006-1022 (1989) (0)
Novel interacting partners suggest roles for NBR1 in bone remodeling and protein degradation (2010) (0)
Molecular and cytogenetic assessment of patients with acute promyelocytic leukaemia (APL) entered into the UK MRC ATRA trial [Abstract] (1995) (0)
Human Gene Mapping 11: London Conference 1991 11th International Workshop, New Connaught Rooms, London, August 1991 (1992) (0)
Familial Breast/ovarian Cancer - Progress Towards Isolation of a Predisposing Gene (1994) (0)
Characterisation of PLZF-RARα associated APL; identification of cases with crykptic rearrangements lacking the t(11;17) (2000) (0)
Radiosensitivity in breast cancer susceptibility. (2005) (0)
Chromosomal assignments ofthegenescoding forhumantypes II, III, andIVcollagen: A dispersed genefamily (1985) (0)
Chromosome radiosensitivity and apoptosis in breast cancer susceptibility. (2005) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Ellen Solomon?

Ellen Solomon is affiliated with the following schools:

Ellen Solomon's Academic­Influence.com Rankings

Why Is Ellen Solomon Influential?

Ellen Solomon's Published Works

Published Works

What Schools Are Affiliated With Ellen Solomon?

Ellen Solomon's AcademicInfluence.com Rankings